Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease-Reference-Cited by-同舟云学术

Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease

Published:2012-05 Issue:5 Volume:163 Page:844-850.e1
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Shah Svati H.,Sun Jie-Lena,Stevens Robert D.,Bain James R.,Muehlbauer Michael J.,Pieper Karen S.,Haynes Carol,Hauser Elizabeth R.,Kraus William E.,Granger Christopher B.,Newgard Christopher B.,Califf Robert M.,Newby L. Kristin

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Heart and stroke statistical update;American Heart Association,2008

2. Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee;Rosamond;Circulation,2008

3. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance;An;Nat Med,2004

4. Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry;Chace;Clin Chem,1995

Cited by 277 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Advanced Metabonomic Technologies on Surgical Interventions: A Comprehensive Review;Egyptian Journal of Chemistry;2024-08-21

2. Circulating Metabolite Profiles and Risk of Coronary Heart Disease Among Racially and Geographically Diverse Populations;Circulation: Genomic and Precision Medicine;2024-08

3. Genetic drivers of human plasma metabolites that determine mortality in heart failure patients with reduced ejection fraction;Frontiers in Cardiovascular Medicine;2024-07-09

4. Duality of Branched-Chain Amino Acids in Chronic Cardiovascular Disease: Potential Biomarkers versus Active Pathophysiological Promoters;Nutrients;2024-06-20

5. Metabolomics data improve 10-year cardiovascular risk prediction with the SCORE2 algorithm for the general population without cardiovascular disease or diabetes;2024-05-04